Cost-Effectiveness Analysis of Combined Chemotherapy Regimen Containing Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis in China

CONCLUSION: BR is shown to be cost effective. When the unit price of Bedaquiline reaches or falls below 57.21 yuan per unit, BR is expected to be the dominant strategy in China over CR.PMID:37424243 | DOI:10.3967/bes2023.061

Source: Biomedical and Environmental Sciences : BES - July 10, 2023 Category: Biomedical Science Authors: Cai Hong Xu Ying Peng Qiu Zi Long He Dong Mei Hu Xiao Yue Zhong Dan Chen Yuan Yuan Xu Yan Lin Zhao Source Type: research